Cited by 256Advanced Glycation End Products researchCardiac Ischemia and ReperfusionAcute Kidney Injury Research

Receptor for Advanced-Glycation End Products: Key Modulator of Myocardial Ischemic Injury

Bucciarelli, Loredana G., Kaneko, Michiyo, Ananthakrishnan, Radha, Harja, Evis, Lee, Larisse K., Hwang, Yuying C., Lerner, Shulamit, Bakr, Soliman +9 more·2006·Circulation

Abstract

Background— The beneficial effects of reperfusion therapies have been limited by the amount of ischemic damage that occurs before reperfusion. To enable development of interventions to reduce cell injury, our research has focused on understanding mechanisms involved in cardiac cell death after ischemia/reperfusion (I/R) injury. In this context, our laboratory has been investigating the role of the receptor for advanced-glycation end products (RAGE) in myocardial I/R injury. Methods and Results— In this study we tested the hypothesis that RAGE is a key modulator of I/R injury in the myocardium. In ischemic rat hearts, expression of RAGE and its ligands was significantly enhanced. Pretreatment of rats with sRAGE, a decoy soluble part of RAGE receptor, reduced ischemic injury and improved functional recovery of myocardium. To specifically dissect the impact of RAGE, hearts from homozygous RAGE-null mice were isolated, perfused, and subjected to I/R. RAGE-null mice were strikingly protected from the adverse impact of I/R injury in the heart, as indicated by decreased release of LDH, improved functional recovery, and increased adenosine triphosphate (ATP). In rats and mice, activation of the RAGE axis was associated with increases in inducible nitric oxide synthase expression and levels of nitric oxide, cyclic guanosine monophosphate (cGMP), and nitrotyrosine. Conclusions— These findings demonstrate novel and key roles for RAGE in I/R injury in the heart. The findings also demonstrate that the interaction of RAGE with advanced-glycation end products affects myocardial energy metabolism and function during I/R.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.105.575993

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In cardiomyocytes, AGEs regulate the response to ischemia-reperfusion injury via modulation of cardiac energy metabolism.

    “Furthermore, it has been suggested that in cardiomyocytes AGEs regulate the response to ischemia-reperfusion injury via modulation of cardiac energy metabolism (33).”

    From Cardiac remodeling in obesity (2008) · cites this paper as [33]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Kislinger T, Fu C, Huber B, Qu W, Taguchi A, Yan SD, Hofmann M, Yan SF, Pischetsrieder M, Stern D, Schmidt AM. N(epsilon)- (carboxymethyl)lysine modifications of proteins are ligands for RAGE that activate cell signalling pathways and modulate gene expression. J Biol Chem. 1999;274:31740 -31749.
  2. Marin-Garcia J, Ananthakrishnan R, Agrawal N, Goldenthal MJ. Mito- chondrial gene expression during bovine cardiac growth and devel- opment. J Mol Cell Cardiol. 1994;26:1029 -1036.

Cited by

Sorted by citations

Authors
Bucciarelli, L. G., Kaneko, M., Ananthakrishnan, R., Harja, E., Lee, L. K., Hwang, Y. C., Lerner, S., Bakr, S., Li, Q., Lu, Y., Song, F., Qu, W., Gomez, T., Zou, Y. S., Yan, S. F., Schmidt, A. M., & Ramasamy, R.
Affiliations
Columbia University Irving Medical Center (US)
Venue
Circulation
Published
2006-03-07
Volume
113
Issue
9
Pages
1226-1234
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2148329662
Cited by
256
References
40
Citations by year
2026: 6 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 7 · 2021: 15 · 2020: 13 · 2019: 9 · 2018: 7 · 2017: 11 · 2016: 13 · 2015: 16 · 2014: 9 · 2013: 27 · 2012: 17
FWCI
13.82
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Juvenile Diabetes Research Foundation International
  • American Heart Association
  • Fondation Leducq
  • National Heart, Lung, and Blood Institute (P01HL060901, HL 61783, HL60901, R01HL068954, HL68954, R01HL061783)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Cardiac Ischemia and Reperfusion
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
Keywords
receptor for advanced glycation end products, RAGE, myocardial ischemia-reperfusion injury, cardiomyocyte death, soluble RAGE, inducible nitric oxide synthase, nitric oxide, cyclic GMP, nitrotyrosine, myocardial energy metabolism, cardiac function recovery
MeSH terms
Receptor for Advanced Glycation End Products, Animals, Energy Metabolism, Cyclic GMP, Male, Nitric Oxide, Receptors, Immunologic, Tyrosine, Myocardial Reperfusion Injury, Up-Regulation, Myocardial Ischemia, Mice, Knockout, Mice, Rats, Nitric Oxide Synthase Type II

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review